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ABSTRACT
The conserved mRNA export receptor NXF1 (Mex67
in yeast) assembles with messenger ribonucleo-
proteins (mRNP) in the nucleus and guides them
through the nuclear pore complex into the cyto-
plasm. The DEAD family RNA helicase Dbp5
is essential for nuclear export of mRNA and is
thought to dissociate Mex67 from mRNP upon
translocation, thereby generating directional
passage. However, the molecular mechanism by
which Dbp5 recognizes Mex67-containing mRNP
is not clear. Here we report that the human
NXF1-binding protein RBM15 binds specifically
to human DBP5 and facilitates its direct contact
with mRNA in vivo. We found that RBM15
is targeted to the nuclear envelope, where it
colocalizes extensively with DBP5 and NXF1. Gene
silencing of RBM15 leads to cytoplasmic depletion
and nuclear accumulation of general mRNA as
well as individual endogenous transcripts,
indicating that RBM15 is required for efficient
mRNA export. We propose a model in which
RBM15 acts locally at the nuclear pore complex,
by facilitating the recognition of NXF1–mRNP
complexes by DBP5 during translocation, thereby
contributing to efficient mRNA export.
INTRODUCTION
In the course of mRNA metabolism, the protein compo-
sition of messenger ribonucleoprotein complexes (mRNP)
changes in a speciﬁc order and in a strictly regulated
manner. Such changes are assisted by RNP remodeling
enzymes that facilitate the reorganization of RNA:RNA
and RNA:protein contacts [for a recent review, see ref.
(1)]. Of these, the helicase superfamily 2 (SF2) proteins,
DEAD/DExH RNA helicases, act to unwind RNA
helices and/or displace the RNA-bound proteins, in an
ATP-dependent fashion. SF2 factors have been implicated
at all mRNA metabolic steps from transcription to decay
(2–5). In the nucleus, the DExH/D protein eIF4AIII (6,7)
and the splicing/nuclear export factor Sub2/UAP56 (8–12)
participate in the assembly of export-ready mRNP, and
DEAD-box protein Dbp5 (DBP5/DDX19 in humans) is
thought to assist the translocation of mRNP through
the nuclear pore complex (NPC). Dbp5 is essential for
mRNA export in yeast (13–15), and studies in metazoa
revealed a remarkably conserved network of interactions
between its orthologs and their binding partners, suggest-
ing a conserved mechanism by which Dbp5 acts on
translocating mRNP to generate directional passage
(16–18). In a current model, Dbp5 is targeted to the
cytoplasmic ﬁbrils of NPC via interactions with the
nucleoporin Nup159/NUP214, while its binding partner
Gle1 interacts with the nucleoporin-like protein Nup42/
Rip1/hCG1 at an adjacent site on the NPC, leading
to the facilitated formation of Dbp5–Gle1 complex.
The RNA binding and ATPase activities of Dbp5 are
enhanced by Gle1 and inositol hexakisphosphate, and
hence the complex formation results in Dbp5’s activation
at the precisely deﬁned locale, the cytoplasmic side of the
NPC (19–21). Dbp5 is then thought to dissociate the
export receptor Mex67/NXF1 from mRNP complexes as
they emerge at the cytoplasmic side of NPC, and thus
confer direction to the NPC passage (19,20,22,23). In
this scenario, the spatial restriction of Dbp5 activity
prevents premature mRNP remodeling. Recent work
showed that Dbp5 can promote the dissociation of Nab2
mRNA export factor as well as polyadenylate-binding
protein Pab1 from the bound RNA in vitro (24), conﬁrm-
ing its predicted RNP remodeling activity and suggesting
that it can act on a variety of RNP substrates. A recently
discovered role of Dbp5 in translation termination (25)
further supports its promiscuity. The mechanism that
directs Dbp5 speciﬁcally to the Mex67/NXF1-containing
mRNP during export and prevents its non-productive
eﬀects on other exported RNP remains to be elucidated.
There is no evidence of direct recognition between the
yeast Mex67 and Dbp5, and we previously reported that
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directly in vitro (26), supporting the lack of constitutive
interaction. We reasoned that the DBP5–NXF1 recogni-
tion could be enabled transiently, by a cofactor that
only acts at the NPC, thereby allowing DBP5 to target
the NXF1-containing mRNP selectively and at a proper
location.
Here, we report that the human RNA binding motif
protein 15 (RBM15) has properties expected from a
factor that facilitates the contacts of DBP5 with mRNA
at NPC. RBM15 belongs to the Spen (split end) family
of proteins, which share domain architecture including
three N-terminal RNA recognition motifs (RRM) and
a C-terminal SPOC (Spen paralogue and orthologue
C-terminal) domain, and are conserved across metazoa.
In humans, the Spen proteins are represented by
SHARP, RBM15 (also referred to as OTT1) and
RBM15B/OTT3 (herein referred to as OTT3). The mam-
malian RBM15 orthologs have been implicated in
hematopoiesis (27), transcription regulation (28), mRNA
export and splicing (29,30). Our previous work showed
that RBM15 binds to NXF1 and serves as receptor for
the RNA export element RTE (30). RTE utilizes the
NXF1 export pathway in microinjected X. laevis oocytes
(30), synergizes in cis with NXF1’s high aﬃnity RNA
ligand CTE (31) and is essential for propagation of
murine LTR-IAP retrotransposons (32), suggesting that
RBM15 is a bona ﬁde general mRNA export factor that
is hijacked by mobile elements to achieve the eﬃcient
export of their otherwise defective, nuclear-retained
transcripts (32). While studies of retroelements revealed
the mRNA export activity of RBM15, its role in the
general mRNA metabolism remains to be elucidated. In
this work, we show that RBM15 is required for the eﬃ-
cient mRNA export in human cultured cells, and propose
the underlying mechanism.
MATERIALS AND METHODS
Cell culture, antibodies, immunoprecipitation and
in vivo cross-linking
The mammalian expression plasmids for RBM15,
DBP5 and NXF1, and GST fusion plasmids for NXF1
and DBP5 were described (15,30,33). Transfections
in human 293 or HeLa-derived HLtat cells were per-
formed as described (33). Cell ﬁxation and permeabili-
zation were performed as in ref. (34). For indirect
immunoﬂuorescence, RBM15pAb (10587-1-AP,
Proteintech), NXF1mAb (53H8, Santa Cruz),
DBP5pAb (A300-547A, Bethyl Labs), SC-35mAb (SC-
35, Sigma), HA epitope mAb (HA.11, Covance) and
FLAG-epitope mAb (M2, Sigma) were used as primary
antibodies, followed by detection with Alexa-conjugated
secondary antibodies (Molecular Probes), according to
the manufacturers’ instructions. The endogenous SR
proteins were detected on western blots using 1H4mAb
(Zymed) that recognizes a phospho-epitope common
for all members of the SR protein family. For coimmuno-
precipitation assays, cells were extracted under mild
conditions (200mM NaCl, 0.5% Triton X100), treated
with RNase A prior to immunoprecipitation with anti-
FLAG agarose (Sigma), and the complexes were eluted
with 3XFLAG peptide (Sigma) to ensure that only
soluble, RNA-independent complexes were analyzed.
UV-crosslinking in vivo was performed as in ref. (35)
with 400mJ energy dose, and poly(A)+ RNA was
isolated using Dynabeads mRNA DIRECT procedure.
Image analysis
The wide-ﬁeld epiﬂuorescence images were acquired using
Axio Observer Z1 microscope equipped with AxioCam
MRM CCD camera, PlanApo 100X objective, appropri-
ate ﬁlter sets and AxioVision software (Carl Zeiss
Microimaging, Thornwood, NY). The multi-color
experiments were performed using appropriate controls
to exclude leakage between the channels. Some images
were acquired as Z-stacks and subjected to 3D digital
deconvolution using AutoDeblur software (Bitplane,
Saint Paul, MN). Quantitative colocalization analyses
(QCA) were performed using the orthogonal regression
as well as expectation maximization algorithms, imple-
mented in MIPAV software (CIT, NIH) with default
parameters.
Posttranscriptional gene silencing
Shortly after seeding in 60-mm plates, 293 cells were trans-
fected with ON-TARGETplus SMARTpool siRNAs
(Dharmacon) for RBM15 (sense strands: ACGAGAAU
UUGAUCGAUUUUU, GGUGAUAGUUGGGCAUA
UAUU, UAGCAGGGCCCAAUGGUUAUU, GCAG
UAGCCGGGAUCGUUAUU), OTT3 (sense strands: G
GGAGCAGUCGGCGAAGUAUU, CCAUAUGAGG
AACGGAGUAUU, CUACAGAGACGGCCGAAA
UUU, UGAGAAGGGAAUCCGGUUAUU) or non-
targeting control, at 100nM, by using HiPerFect reagent
(Qiagen). At day 2 post-transfection, cells were trypsini-
zed, split at 1:3 and transfected again under the same
conditions.
Cell fractionation and quantitative RT–PCR
Human 293 cells were extracted sequentially with 10mM
HEPES pH 7.9, 1mM MgCl2, 2mM NaCl, 0.5mM DTT
and 0.004% digitonin (C fraction, soluble cytoplasmic);
and 20mM HEPES pH 7.9, 1mM MgCl2, 100mM
NaCl, 0.5mM DTT, 0.5% Triton X100 and 10%
glycerol (N1 fraction, soluble nuclear). The remaining
pellet was resuspended in the N1 buﬀer and solubilized
by sonication as in ref. (36) yielding the N2 fraction (insol-
uble nuclear). All extractions were performed at +4 C.
Alternatively, cells were extracted with 15mM HEPES,
pH 7.9, 50mM KCl, 200mM NaCl, 0.1mM EDTA and
0.2% Triton X100 (‘soluble cell fraction’ corresponding to
C+N1). Poly(A)+ RNA was puriﬁed using Dynabeads
mRNA DIRECT procedure. After reverse transcription
with SuperScript III (Invitrogen) and random hexadeoxy-
nucleotide primers, real time quantitative PCR (qPCR)
was performed using ABI PRISM 7700 Sequence
Detection System (Applied Biosystems). The TaqMan
gene expression assays (primer sets) for b-actin
(ACTB, cat #4333762), glyceraldehyde 3-phosphate
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hexakisphosphate kinase 1 (IP6K1, assay ID:
Hs00384812_m1) were purchased from Applied
Biosystems. Reactions were performed in triplicate using
the default cycling conditions as recommended by the
manufacturer, and data were analyzed using the relative
quantiﬁcation method, in which the experimental Ct
values (the number of cycles required for the ampliﬁcation
signal to surpass a set threshold) were used to calculate the
relative cDNA input concentrations (I):I=2
 (Ct Co)
where Co is a calibration constant The background
levels were obtained from control reactions with omitted
template, and typically were at least two orders of magni-
tude lower than the mRNA signal. Datasets were
compared using one-way analysis of variance (ANOVA)
(a=0.05) with Bonferroni or Newman–Keuls post-tests.
Detection of general mRNA, tRNA and U snRNP
For general mRNA detection, poly(A)+ RNA was
30-labeled with [
32P] pCp (NEN) using T4 RNA ligase
(Fermentas), followed by complete digestion with RNase
T1 (Worthington). After additional round of oligo(dT)
capture using Dynabeads mRNA DIRECT procedure,
the isolated poly(A) tails were separated on 15% TBE–
urea gels and detected by phosphoimager. For tRNA and
U snRNP detection, total RNA was puriﬁed from
subcellular extracts by proteinase K digestion and
RNAzol extraction, and separated on 15% TBE–urea
gels. tRNA was visualized by ethidium bromide staining,
and U snRNAs were detected on northern blots as
described (37).
RESULTS
RBM15 binds speciﬁcally to DBP5 in vivo and in vitro
To probe the association between RBM15 and DBP5
in vivo, we immunoprecipitated the epitope-tagged pro-
teins from the extracts of transfected cells, which were
pretreated with RNase A to exclude RNA-mediated
interactions. We found that DBP5 associated eﬃciently
with RBM15, while OTT3 exhibited a weaker association
(Figure 1A). This interaction was mediated by RBM15’s
C-terminal region (aa 530–977) that also binds NXF1 (30),
while the N-terminal region containing the RRM motifs
Figure 1. RBM15 associates with DBP5 in vivo and in vitro. The expression plasmids encoding epitope-tagged proteins (1–5mg each) were transiently
transfected in human 293 cells as indicated, and coprecipitation assays were performed from RNase A-treated extracts (30). (A–C) The extracts were
adjusted to 400mM NaCl before adding the antibodies, and the precipitates were washed in the presence of 400mM NaCl and 2M urea prior to
elution. The epitopes detected on western blots and the positions of detected proteins are indicated. Input, 1:100 of the extract before IP; Control,
omission of bait protein and n/t, non-transfected cells. (D) Binding of E.coli-produced, immobilized GST-tagged DBP5 or isolated GST moiety
(left panel, GST proteins) to metabolically radiolabeled RBM15 and luciferase (Luc) proteins which were synthesized in reticulocyte lysates (input)
(26). Prior to binding, RNase A was added to reticulocyte samples to exclude the RNA-mediated interactions. Right panel (GST pulldowns),
SDS–PAGE/radioﬂuorography analysis of the bound fractions. Asterisk shows a truncated RBM15 protein.
Nucleic Acids Research, 2009,Vol.37, No. 21 7153(aa 1–530) did not associate (Figure 1B). We further
evaluated the selectivity of the RBM15–DBP5 binding
by studying RBM15’s interactions with other mammalian
RNA-binding proteins implicated in the assembly and/or
remodeling of mRNA export complexes: Y14 (38–40),
9G8 (41–43), U2AF35 (37,44,45), REF1-II and REF2-II
(46–50). As negative control, we used the DExH/D RNA
helicase UAP56 (8,11,12,51), which is essential for mRNA
export in human cells (52) and was shown not to bind
RBM15 (30). These factors were HA-tagged and
expressed in the presence of FLAG-tagged RBM15.
Immunoprecipitations with FLAG antibodies were per-
formed from RNase-digested extracts in the presence of
2M urea and 400mM NaCl to ensure stringent
conditions. We found that RBM15 discriminated eﬃ-
ciently between DBP5 and a structurally similar (32%
identity) UAP56 (Figure 1C), indicating that DBP5’s
ability to bind RBM15 was selective and not a generic
property of SF2 proteins. Under these conditions,
RBM15 did not bind appreciably to Aly/REF proteins
REF1-II and REF2-II, or Y14 and 9G8. We noted a
strong association between RBM15 and U2AF35, an SR
family RRM motif-containing splicing factor that binds
NXF1 directly (37), but it was not shared by other SR
proteins (9G8), NXF1 binders (9G8, Aly/REF) or the
RRM motif-containing proteins (9G8, Y14, Aly/REF)
(Figure 1C). The interaction with U2AF35 was consistent
with the previously reported association of RBM15 with
the spliceosome (53) and was not further addressed in this
study. We further examined the RBM15-DBP5 binding
in vitro, using pulldowns of reticulocyte-produced
RBM15 with bacterially expressed, puriﬁed GST–DBP5.
RNaseA was added to the reactions to exclude the
RNA-mediated interactions, and ﬁreﬂy luciferase protein
was used as a control for non-speciﬁc binding. These
experiments showed that RBM15 bound speciﬁcally to
DBP5 in vitro (Figure 1D). In summary, our data
revealed that the interactions between RBM15 and
DBP5 are RNA-independent, persist under stringent
conditions and are highly selective. These data suggested
that RBM15 could serve to bridge NXF1 to DBP5.
However, exogenously expressed RBM15 did not stimu-
late signiﬁcantly the co-precipitation of NXF1 and DBP5
proteins from crude extracts (data not shown), leading us
to speculate that RBM15’s bridging activity could be
spatially regulated and restricted to a subpopulation of
NXF1 complexes such as mRNP in transit through NPC.
RBM15 promotes the access of DBP5 to mRNP
complexes
To examine the association of endogenous RBM15 and
DBP5 with general mRNP complexes, we UV-irradiated
human 293 cells and analyzed the proteins that crosslinked
to poly(A)+ RNA, in the cytoplasmic (C), soluble nuclear
(N1) and insoluble nuclear (N2) cell extracts (Figure 2A).
This sequential fractionation protocol allows dissecting
the mRNP maturation stages: N1 contains the mature,
export-ready spliced mRNP, whereas pre-mRNP are
conﬁned to the N2 fraction, which also contains the
bulk of spliceosomal components (36,37,42,54–57). To
analyze the UV-crosslinked proteins, the extracts were
adjusted to high salt and detergent concentrations so
that all non-covalently bound factors were dissociated,
and the covalent poly(A)+ RNA–protein adducts were
puriﬁed by oligo(dT) capturing. The bound proteins
were then released from RNA complexes by RNase diges-
tion and analyzed on western blots. Figure 2A, input,
shows that, in crude extracts, the endogenous RBM15
was strongly enriched in the N2 fraction, consistent with
its spliceosomal association (53), whereas endogenous
DBP5 was mostly cytoplasmic, as expected (15). We
found that RBM15 crosslinked detectably to poly(A)+
RNA, whereas DBP5 as well as b-actin (ACTB) did not
[Figure 2A, poly(A)+]. However, the crosslinked RBM15
was not enriched in the N2 fraction, suggesting that
RBM15 was added to the mature mRNP after splicing.
The above sequential extraction protocol allowed
dissecting the cytoplasmic and soluble nuclear complexes,
but led to poor yields of crosslinked product (Figure 2A).
In subsequent crosslinking experiments, we used a
simultaneously extracted C+N1 fraction (‘soluble
cell fraction’), that provided higher yields (see below,
Figure 2B). In summary, these data showed that
endogenous RBM15 has access to export-ready mRNP
and prompted us to address RBM15’s interactions with
its cofactors within such complexes.
We coexpressed the epitope-tagged NXF1, DBP5 and
RBM15 proteins, and analyzed their interactions with
poly(A)+ RNA in the soluble cell fraction (C+N1)
using UV crosslinking in vivo (Figure 2B and C). We
found that, in the absence of exogenous RBM15, HA-
DBP5 did not crosslink to mRNA eﬃciently (Figure 2B,
lane 1), whereas NXF1 crosslinked strongly, as expected
(35). Remarkably, a modest ( 2-fold; Figure 2B, lane 4;
input) increase in RBM15 levels upon exogenous expres-
sion caused a strong increase in both RBM15 and DBP5
crosslinking to mRNA (Figure 2B, lane 4). Using RBM15
and DBP5 that were both HA-tagged, we found that they
yielded comparable signals in poly(A)+ fraction, suggest-
ing that they crosslinked at comparable molar amounts
(Figure 2C, lane 6), which is consistent with DBP5’s
recruitment via stoichiometric RBM15 binding. The
crosslinking of RBM15 and DBP5 was detectable in
the absence of exogenous NXF1 and did not change
signiﬁcantly in the presence of cotransfected NXF1
(Figure 2C, lanes 5 and 6), suggesting that the endogenous
levels were saturating in our assays. Because RBM15
binds to NXF1 directly (30), it could access mRNP via
direct binding to NXF1, while interactions with other
mRNP proteins and/or naked RNA could also play a
role. Our recent work (58) showed that RBM15 binds
selectively to NXF1’s NTF2-like domain (59) that is not
engaged in mRNP association (37), and thus, RBM15
may be able to bind mRNP-associated NXF1. We
concluded that RBM15 acts as a limiting factor enabling
the access of DBP5 to general mRNA. It cannot be
excluded that the stimulation by RBM15 was indirect,
e.g. reﬂected slower mRNA export rates in the presence
of exogenous RBM15, leading to extend the dwelling time
of DBP5 in the vicinity of translocating mRNA. However,
the exogenous expression of RBM15 or its deletion
7154 Nucleic Acids Research, 2009,Vol.37, No. 21mutants did not cause mRNA export inhibition (30) or
excessive accumulation of poly(A)+ RNA or DBP5 at
the nuclear envelope (data not shown), and hence there
is no evidence to support an indirect stimulation. Taken
together with the direct binding and highly selective, stable
interactions between DBP5 and RBM15 (Figure 1), our
results strongly favor the direct recruitment.
To understand the recruitment mechanism, we
examined the responsible determinants within RBM15.
We found that the N-terminal region of RBM15 com-
prising the RRM motifs (aa 1–530; see Figure 1A)
crosslinked to mRNA eﬃciently (Figure 2C, lane 4),
possibly reﬂecting its ability to bind RNA directly (30),
but failed to recruit DBP5. Thus, the presence of RBM15’s
C-terminal region (aa 530–977) that contains the NXF1-
and DBP5-binding determinants was critical, further sug-
gesting that DBP5 was recruited via direct binding.
Our data are compatible with two mechanisms: (i) DBP5
binds directly to the mRNP-bound RBM15; (ii) RBM15
acts allosterically to induce the direct binding between
DBP5 and mRNP components other than RBM15.
Importantly, the isolated C-terminal region did not
crosslink or recruit DBP5 (Figure 2C, lane 3), demonstra-
ting a critical role of the N-terminal region (aa 1–530).
While this role could be limited to the maintenance of
direct contacts with mRNA (Figure 2C, lane 4), it is
also possible that RBM15’s N-terminal region could
contribute to DBP5 recruitment by targeting RBM15 to
the vicinity of mRNP remodeling.
RBM15 is targeted to the nuclear envelope via its
N-terminal region
To further address the mechanism of DBP5 recruitment,
we examined the subcellular localization of RBM15 in
cultured human cells, and compared it to that of NXF1
and DBP5. Using indirect ﬂuorescence to detect the
endogenous proteins, we found that in paraformaldehyde
(PFA)-ﬁxed HeLa cells (Figure 3A) RBM15 localized
to the nucleoplasm and was undetectable at the
nuclear envelope (NE), whereas NXF1 displayed both
nucleoplasmic and NE localization as expected (33,35).
Similar localization was observed after methanol ﬁxation
(not shown). Under the same conditions, in 293 cells
(Figure 3B), endogenous RBM15 also localized to the
nucleoplasm and partially colocalized with SC35 antigen
in nuclear speckles, indicating its enrichment in splicing
factor compartment (SFC), as expected from the
previous characterization of RBM15 as a spliceosome-
associated protein (53). Previously, we observed that in
HeLa cells, the endogenous RBM15 was not enriched in
SFC at steady state, but the exogenously expressed protein
accumulated readily in SFC, conﬁrming that RBM15 has
access to this compartment (58).
Figure 2. RBM15 stimulates crosslinking of DBP5 to mRNA. (A) Exponentially growing human 293 cells were UV-irradiated with a dose of 400mJ
when indicated (UV+) and fractionated into the C, N1 and N2 extracts. Poly(A)+RNA was isolated under denaturing conditions, and the
endogenous RBM15, DBP5 and, as negative control, ACTB proteins were analyzed in the poly(A)+ fractions on Western blots, after RNase
digestion (polyA+); and in 1:1000 aliquots of crude extracts (input). (B and C) Human 293 cells were transiently transfected with 1mg of HA-NXF1,
1mg of HA-DBP5, and the indicated amounts of HA-RBM15 plasmids (B) or with 1mg of each of the indicated plasmid (C). At day 1
posttransfection, cells were UV-irradiated (B, lanes 1–4; C, lanes 1–6) as in (A). Poly(A)+ RNA was isolated from soluble cell fractions
(C+N1), and the crosslinked proteins were analyzed as in (A). Input, a 1:200 aliquot of crude extract. The positions of proteins and the antibodies
used are indicated. In panel B, staining with the RBM15 antibody (pAb 10587-1-AP, Proteintech) detected both the exogenous and endogenous
proteins with the expected mobility diﬀerence [endogenous, isoform 2-L, 100kDa; exogenous, HA-tagged isoform 1 S+AE, 108kDa (30)]. The
identity of the crosslinked DBP5 bands was veriﬁed by staining with protein-speciﬁc antibodies (data not shown). Similar data were obtained in three
independent transfection experiments.
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proteins is best viewed upon cell extraction, which
removes the loosely bound fraction while preserving the
strong association. Permeabilization of cells during or
prior to ﬁxation is commonly used to study the strong
NPC binders, e.g. NXF1 (60). We therefore performed
indirect immunoﬂuorescence in HeLa cells ﬁxed with
glutaraldehyde (GA) in the presence of Triton X100
(Figure 3C). We found that, in all cells, a fraction of
the endogenous RBM15 associated with NE, where it
colocalized with NXF1 (Figure 3C). Staining of unﬁxed
Triton X100-permeabilized cells, a technique that has
previously been used to visualize the NPC-bound DBP5
(15) and NXF1 (60), provides an even higher degree of
extraction. Remarkably, using this technique, an extensive
and persistent association of RBM15 as well as of NXF1
with the NE was revealed in all cells (Figure 3D). No
signal was detected at the NE after staining for nuclear
non-NPC antigens including SC35 or upon omission of
primary antibodies, and the integrity of nuclear
membranes was conﬁrmed by staining with ﬂuorescent
lipophilic dye DiOC6 (61) (data not shown). We
concluded that the endogenous RBM15 resides mostly in
the nucleoplasm at steady state, while a fraction of the
protein is present at the nuclear envelope. It is possible
that poor epitope accessibility contributed to the lack of
RBM15 signal at the NE of cells that were ﬁxed prior to
permeabilization (Figure 3A and B), prompting us to
examine the epitope-tagged proteins. We found that the
exogenously expressed HA-tagged as well as FLAG-
tagged RBM15 accumulated strongly at the NE (Figure
3E and F). The nuclear envelope-targeting determinant
resided entirely within its N-terminal region, whereas
the C-terminal region accounted for the nucleoplasmic
localization (Figure 3F). Under these conditions, the
endogenous DBP5 was found in the cytoplasm and at
the NE as expected (15) and colocalized with HA-
RBM15 at the NE (Figure 3E). Post-embedment
immunoelectron microscopy of the same cells conﬁrmed
the colocalization of HA-RBM15 and DBP5 at NPC (data
not shown). RBM15’s isolated N-terminal region also
associated prominently with the perinuclear compartment
(PN) ﬂanking the cytoplasmic side of the nuclear envelope
(Figure 3F), but it did not colocalize signiﬁcantly with
the known PN components such as the ER and the
perinuclear actin ﬁlaments (62), and these conclusions
were conﬁrmed by using quantitative colocalization
analyses (data not shown).
In summary, RBM15 colocalized at the nuclear
envelope with the NPC-associated DBP5 and NXF1,
strongly suggesting the presence of a dedicated NPC tar-
geting signal. The NPC association does not require the
presence of its C-terminal region, which is responsible
for binding to DBP5–NXF1. However, only a fraction
of the endogenous protein resides at the NPC at steady
state, which could be due to short dwelling time and/or
low aﬃnity. The exogenously expressed HA-RBM15
accumulated extensively at the NPC, suggesting that
this compartment could be relevant for the observed
RBM15-driven recruitment of DBP5 to mRNP
(Figure 2A and B). These ﬁndings further indicate that
the DBP5–mRNA recognition could be facilitated
by high local concentrations of RBM15 at the NPC.
We conclude that RBM15 has properties of a factor
that acts at the NPC to facilitate the access of DBP5
to mRNA, and further address its relevance for general
mRNA export.
Figure 3. RBM15 is targeted to SFC and nuclear envelope. (A–E)
Detection by indirect immunoﬂuorescence: (A) Endogenous RBM15
and NXF1 in HLtat cells after PFA ﬁxation followed by Triton
X100 permeabilization. (B) Endogenous RBM15 and SC35 in human
293 cells after PFA ﬁxation followed by Triton X100 permeabilization.
(C) Endogenous RBM15 and NXF1 in HLtat cells after ﬁxation with
4% glutaraldehyde in the presence of 0.5 % Triton X100. (D)
Endogenous RBM15 and NXF1 in permeabilized HLtat cells.
Preformed complexes of the primary and secondary antibodies in
PBS were added to live cells, followed by addition in situ of Triton
X100 to 0.5%, and images were captured after 15min incubation at
room temperature. (E) HA-tagged RBM15 and endogenous DBP5 in
HLtat cells after methanol ﬁxation and Triton X100 permeabilization.
(F) FLAG-tagged RBM15 (wild type and mutants spanning aa 1–530
and aa 530–977) in HLtat cells after methanol ﬁxation and Triton X100
permeabilization. Inverted images are shown. Signals were visualized by
wideﬁeld epiﬂuorescence microscopy, and sections through the centre of
the nucleus are presented. Raw (A, B, D, F) and digitally deconvoluted
(C, E) images are shown. Typical ﬁelds are presented, and similar
results were obtained in three independent experiments. Bars, 20mm
(A, B, C, D and F), 10mm (E).
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mRNA export inhibition
To examine the participation of RBM15 and OTT3 in
general mRNA export, we performed posttranscriptional
gene silencing in human 293 cells with siRNAs directed
either to RBM15 or to its cognate protein OTT3 or using
a non-targeting siRNA as control. To evaluate the mRNA
target speciﬁcity, we used quantitative RT–PCR (RT–
qPCR) to measure the levels of the endogenous RBM15
and OTT3 transcripts. We found that RBM15 and OTT3
siRNAs caused an appreciable reduction of their target
transcript levels, whereas those of non-targeted transcripts
were not reduced (Figure 4A), suggesting the absence
of oﬀ-target eﬀects on mRNA level. To analyze the
protein depletion, OTT3 was tagged with an HA epitope
to facilitate detection and was analyzed on Western
blots along with the endogenous RBM15. We found
that both RBM15 and OTT3 siRNAs caused strong,
speciﬁc depletions of their targeted proteins, by day 2
and 4, respectively (Figure 4B), and similar data were
obtained with diﬀerent siRNA doses (data not shown).
Interestingly, RBM15 siRNA also led to codepletion of
OTT3 protein by day 4, while the levels of b-actin
and Ran control proteins were not aﬀected (Figure 4B).
We further analyzed the proteins in raw extracts by SDS–
PAGE/Coomassie staining, which is a standard approach
to assess siRNA speciﬁcity, allowing to visualize multiple
proteins simultaneously. We found that in the same
samples as in Figure 4B day 4, there were no appreciable
oﬀ-target eﬀects of RBM15 or OTT3 siRNAs (Figure 4B,
Coomassie). To ask whether the depletions aﬀected gener-
ically the factors that are, like RBM15 and OTT3,
involved in mRNA metabolism, we analyzed the SR
proteins, a family of RNA-binding factors that have
been implicated at all mRNA metabolic steps [for recent
review, see ref. (63)]. Using a monoclonal antibody to a
family-speciﬁc shared epitope, we detected multiple SR
factors, as expected, and found that neither of those
were depleted by day 4 after RBM15 or OTT3 siRNA
transfection (Figure 4B, SR proteins). Together, these
studies established that the targeted RBM15 and OTT3
depletions as well as the OTT3 codepletion by RBM15
Figure 4. RBM15 and OTT3 are required for general mRNA export. Human 293 cells were transfected with siRNAs targeting RBM15, OTT3 or
non-targeting siRNA (control) and analyzed at day 2 or 4 posttransfection as indicated. (A) RT–qPCR detection of RBM15 and OTT3 transcripts at
day 2. Expression levels were calculated from real-time PCR values (Ct) using relative quantitation method and are plotted on the y-axis after
normalization to those obtained in the cells transfected with the non-targeting siRNA control (normalized expression). Mean (n=3) values are
presented, and bars show one SEM. (B) Cells were transfected with the indicated siRNAs and, next day, with a plasmid expressing HA-OTT3 (1mg).
At day 2 or day 4 after siRNA transfection, cell pellets were boiled in Laemmli sample buﬀer, proteins separated on 10% SDS–PAGE and analyzed
on western blots with antibodies to RBM15, HA, Ran, b-actin or SR proteins as indicated; or by Coomassie staining. (C) Cells at day 2 (left panel)
or day 4 (right panel) posttransfection were separated into the C, N1 and N2 fractions, mRNA poly(A) tails were 30-radiolabeled, cut oﬀ by RNase
T1 digestion, separated by urea–PAGE and detected by phosphoimager. Positions of size markers (nt) are shown. (D) U snRNAs from the same
fractions as in (D) were separated by urea–PAGE and detected on northern blots, and positions of the individual U snRNAs are indicated to the left.
tRNA was detected on the same gels, by ethidium bromide staining prior to blotting (tRNA).
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numerous other proteins. Codepletions on the protein
but not mRNA level have been observed for binding
partners of siRNA-targeted proteins, and are attributable
to protein destabilization upon loss of binding (64–68).
In support of such possibility, we recently found that
RBM15 coprecipitates with OTT3 in vivo, pointing
to their presence in the same complexes (58). However,
it is also possible that codepletion reﬂected indirect
eﬀects of generalized mRNA export inhibition
(Figures 4C and 5).
To evaluate the eﬀects of RBM15 and OTT3 depletions
on mRNA export, we compared the levels of general
mRNA in the cytoplasmic (C), soluble nuclear (N1)
and insoluble nuclear (N2) cell extracts (Figure 2A).
The poly(A)+ RNA from these fractions was
radiolabeled at the 30 ends of poly(A) tails and digested
with RNase T1, leading to the complete hydrolysis of
mRNA body while leaving the poly(A) tail intact. These
isolated, radiolabeled poly(A) tails were further puriﬁed
by oligo(dT) capturing and separated by urea–PAGE
(Figure 4C). This procedure ensured that only the
genuine 30-polyadenylated transcripts were analyzed, and
resulted in eﬃcient detection of poly(A) tails with sizes
typical of mature mRNA ( 60–200 nt) in the C and N1
fractions (Figure 4C), whereas considerably longer ( 200–
250 nt) tails likely belonging to pre-mRNA were detected
in the N2 fractions upon overexposure (data not shown).
Because the analyzed RNA samples consisted of pure
polyadenine and did not contain any internal controls
with which to normalize the puriﬁcation yields and gel
loading, this approach is semiquantitative. We note that
Figure 4D (see below) shows other RNA classes in the
same cell extracts as used in Figure 4C, right panel, pro-
viding external controls.
At day 2 posttransfection, we found that in cells
transfected with non-targeting siRNA, mRNA was
enriched in the C fraction (Figure 4C, left panel), conﬁrm-
ing its eﬃcient export from the nucleus, and similar
distributions were observed in the absence of siRNA or
when using siRNAs targeted to irrelevant genes (data not
shown). In contrast, silencing of RBM15 and OTT3 led to
cytoplasmic reduction, while the nuclear mRNA levels
were not aﬀected appreciably (Figure 4C, left panel). At
day 4, silencing of RBM15 and OTT3 further led to
mRNA accumulation in the N1 fractions that represent
the post-splicing, export-ready mRNP (Figure 4C, right
panel, compare lanes 2, 5 and 8), but not in the N2
fractions, indicating that the accumulation was not due
to spliceosomal sequestration. Because the poly(A)
length distributions in the accumulated species were not
altered detectably (Figure 4C, right panel, compare lanes
2, 5 and 8), these RNAs likely represented intact
transcripts and not decay intermediates. OTT3 silencing
also led to an increase of total mRNA levels at day 4, but
not day 2 (Figure 4C, right panel). These data indicated
that OTT3 silencing primarily aﬀected mRNA export,
while the net mRNA increase reﬂected the long-term
eﬀects, and they were further studied using individual
reporter mRNAs (Figure 5).
Figure 5. Quantiﬁcation of individual transcripts upon RBM15 and
OTT3 silencing. (A) Gene silencing and cell fractionation into the C,
N1 and N2 subcellular extracts were performed as in Figure 4, and the
endogenous IP6K1 and ACTB transcripts were detected by RT–qPCR.
Expression levels were calculated as in Figure 4A, and, for each
subcellular extract, are plotted on the y-axis as a fraction of mean
total cell levels (C+N1+N2) (fraction of total). Means (n=3) are
presented, and bars show one SEM. ***P<0.001, one-way ANOVA
(a=0.05), Bonferroni post-test. (B) A summary of three independent
siRNA experiments. For each transcript, the fold export inhibition
values are nucleocytoplasmic ratios ((N1+N2)/C) upon siRNA treat-
ment (mean of triplicate reactions), normalized to those obtained with
the non-targeting siRNA. For individual experiments, these values are
plotted on the y-axis as shown in the legend, and their means and
standard deviations are presented. *P<0.05; ns, P>0.05, one-way
ANOVA (a=0.05), Newman–Keuls post-test. (C) After gene silencing
as in Figure 4, total RNA was isolated by RNAzol procedure and
analyzed by RT–qPCR as in panel A. For each transcript, mean
total levels (n=3) are plotted on the y-axis after normalization to
those obtained with the non-targeting siRNA (normalized total levels)
and bars show one SEM. For each siRNA, a mean of normalized total
levels for the three transcripts is presented (fold up-regulation).
***P<0.001; ns, P>0.05, one-way ANOVA (a=0.05), Newman–
Keuls post-test.
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aﬀected the export of other RNA classes, we analyzed
the transfer RNA (tRNA) and U snRNP, which are
exported independently of mRNA and of each other
(69–72). In the absence of silencing, tRNA was found in
the C and N1 fractions and exhibited a C/N1 distribution
comparable to that of mRNA, whereas U snRNPs U1,
U2, U4 and U5 were enriched in the N2, yet they were
also prominent in the C and N1 fractions, and U6 was
distributed evenly between the C, N1 and N2 fractions
(Figure 4D, lanes 1–3). This pattern, particularly the
high levels of U6 in the non-spliceosomal compartments,
is characteristic of 293 cells and was expected from our
previous studies (37), further validating the quality of
cell fractionation. We found that RBM15 and OTT3
silencing did not considerably aﬀect the nucleocytoplasmic
distribution of tRNA (Figure 4D, tRNA), but led to
a marked reduction of all U snRNPs in the N2 fraction
(Figure 4D, compare lanes 3, 6 and 9). Indirect immuno-
ﬂuorescence analysis of the endogenous proteins did not
reveal any abnormal localization of NXF1, DBP5 and
SC35 proteins, conﬁrming the integrity of subcellular
compartments and indicating that the reduction of U
snRNPs in the N2 fraction was not accompanied by mor-
phological changes in SFC (data not shown). While
RBM15 silencing caused some decrease in C/N1 ratios
of U1, U2, U4, U6 but not U5 (lanes 4 and 5), the
silencing of OTT3 did not lead to changes (lanes 7 and
8). Since RBM15 is part of the spliceosome (53), associates
with U2AF35 (Figure 1D), and is present in the SFC
(Figure 3B), there could be a direct eﬀect on U snRNP
metabolism. However, the observed redistributions were
not accompanied by a reduction in the nuclear levels
of general mRNA (Figure 4C) or individual spliced
transcripts (Figure 5), indicating that general splicing
was not inhibited. In summary, we concluded that
RBM15 and OTT3 silencing led to general mRNA
export inhibition, whereas the nucleocytoplasmic ratios
of other RNA classes were not signiﬁcantly aﬀected
(tRNA) or were reduced (U snRNPs).
Gene silencing of RBM15 and OTT3 inhibits the export
of endogenous spliced transcripts
Since our general mRNA analysis (Figure 4C) was semi-
quantitative, we quantiﬁed the observed eﬀects using real-
time RT–PCR (RT–qPCR) detection of the endogenous
transcripts representing the abundant (b-actin, ACTB)
and lower abundance (inositol hexakisphosphate kinase
1, IP6K1) species (Figure 5). At day 4, we found that in
the cells transfected with non-targeting siRNA, both
reporters were enriched in the cytoplasmic fraction, as
expected, while silencing of RBM15 as well as of OTT3
led to a signiﬁcant cytoplasmic depletion/nuclear accumu-
lation of IP6K1 and ACTB transcripts (Figure 5A). Under
the same conditions, the export of glyceraldehyde
3-phosphate dehydrogenase (GAPDH) mRNA was
aﬀected to lesser extent, not allowing to evaluate the
signiﬁcance (data not shown). By comparing the
nucleocytoplasmic ratios, we found that OTT3 silencing
caused  10-fold, and RBM15 silencing  5-fold inhibition
of both IP6K1 and ACTB mRNA export (Figure 5B, fold
export inhibition).
To study the eﬀects on the total transcript levels, we
puriﬁed RNA from unfractionated cells and quantiﬁed
the IP6K1, ACTB and GAPDH mRNAs with RT–
qPCR (Figure 5C). These analyses showed an increase
of all reporters at day 4 upon OTT3 depletion, while
RBM15 depletion had a lesser eﬀect (Figure 5C, day 4),
whereas at day 2 neither of the reporters showed an appre-
ciable increase (Figure 5C, day 2). Since all transcripts
analyzed exhibited similar trends, we averaged their
up-regulation values for each siRNA treatment (Figure
5C, fold up-regulation) and found them in good agree-
ment with the general mRNA data (Figure 4C), verifying
an increase of general mRNA levels at later stages of
OTT3 depletion. In summary, our analyses of individual
transcripts conﬁrmed that RBM15 and OTT3 silencing led
to a speciﬁc inhibition of mRNA export. The observed
mRNA export phenotypes strongly suggest that RBM15
and OTT3 are necessary to support the physiological
mRNA export rates in human cultured cells.
DISCUSSION
This work shows that a previously described mRNA
export factor RBM15 (30) and its cognate OTT3 protein
(29) are necessary for the eﬃcient nuclear export of
general mRNA, and that RBM15 can facilitate the
access of DBP5 to mRNP. The mRNA export phenotype
of OTT3 is in agreement with our work showing that both
RBM15 (30) and OTT3 (58) possess mRNA export
activity. While RBM15 and OTT3 might have related
but independent roles in mRNA metabolism, it is also
possible that the two proteins are integral parts of one
functional entity, so that a depletion of either component
aﬀects the function. Our recent work supports the latter
view and suggests that RBM15 and OTT3 can form mixed
complexes in vivo (58). Further studies are required to
understand the molecular details and functional relevance
of RBM15–OTT3 association. We noted that RBM15
and OTT3 silencing did not lead to a complete block of
mRNA export and cell death. Although this could be
attributed to incomplete depletions, we favor the view
that RBM15 and OTT3 act to increase the eﬃciency of
mRNA export rather than being indispensable for the
basic translocation mechanism. In support of this idea,
stable shRNA-mediated depletions of the RBM15
ortholog in mouse cultured cells were non-lethal (28);
whereas mouse genetic knockouts caused drastic changes
of mRNA expression proﬁles in homozygous embryos,
but these embryos survived until a relatively late
developmental stage (27,58,73), pointing to a defect less
severe than that of e.g. NXF1 depletion (74,75).
Regarding the contribution of Dbp5/Gle1 to metazoan
mRNA export, RNAi interference with the orthologues
of Dbp5 and Gle1 as well as Dbp5-binding nucleoporin
Nup159 did not lead to general mRNA export block
in Drosophila cultured cells (11,76). In mammals, the
Dbp5/Gle1 mechanism remains to be studied systemati-
cally, yet it is interesting to note that siRNA silencing of
Nucleic Acids Research, 2009,Vol.37, No. 21 7159Nup42/Rip1/hCG1 as well as Nup159/NUP214 in human
cells had subtle mRNA phenotypes and did not block the
general export (23,77), whereas homozygosity for mutant
human GLE1 alleles led to a neurological condition that
was late embryonic lethal, and was accompanied by
changes in mRNA expression proﬁles (78,79). Thus,
some components of the Dbp5/Gle1 machinery in
metazoa could be dispensable for the basic, constitutive
mRNA export, suggesting their more specialized or/and
regulatory roles. Similarly, the strong yet non-lethal
mRNA export phenotypes of RBM15 and OTT3 knock-
downs are compatible with regulatory roles. Plausibly, the
ability of RBM15 to bind DBP5 and NXF1 and to recruit
DBP5 to mRNA could be key to such roles. We propose
a model in which RBM15 directs DBP5 to NXF1-mRNP
complexes at the NPC and precludes DBP5’s non-
productive engagement with other RNP, thereby acting
to promote the NXF1-mRNP remodeling and serving as
a speciﬁcity control of export substrate. In this scenario,
RBM15’s loss of function is expected to reduce the access
of DBP5 to mRNA at NPC and consequently lower the
export rates, in agreement with our gene silencing data.
Because DBP5 did not crosslink to mRNA signiﬁcantly at
physiological RBM15 concentrations, our assays could
not address directly the eﬀects of RBM15 depletion on
DBP5–mRNA interactions, and further studies are
needed to delineate the aﬀected steps. We noted that the
transcripts that responded to silencing were spliced, had
poly(A) tails indicative of intact, mature mRNA and
accumulated in the soluble nuclear fraction, suggesting
they were part of post-splicing, export-ready mRNP
complexes (36,37,42,54–56) and pointing to a likely
defect in NPC translocation. Our model further implies
that a direct, high aﬃnity binding of pre-mRNA to
RBM15 may allow targeting to DBP5 in a manner that
is independent of splicing-mediated NXF1 deposition,
resulting in export prior to splicing. Indeed, our previous
work showed that the otherwise nuclear-retained,
unspliced CAT transcripts were eﬃciently exported from
the nucleus upon tethering of RBM15’s NXF1 and DBP5-
binding region (30), and similar activity was demonstrated
for OTT3 (58). Importantly, our model was drawn from
studies of mammalian proteins. Because there are no
known lethal alleles or RNAi for the putative RBM15
and OTT3 orthologs in C. elegans and D. melanogaster,
they could be non-essential, and there are no obvious
structural homologs in yeast. We therefore speculate
that RBM15 could be a recent acquisition by the ancient
Mex67/Dbp5 machinery, and future studies may reveal
older mechanism(s) ensuring Dbp5’s selective action on
Mex67-containing mRNA. Our study has identiﬁed a
crucial function for human RBM15 protein in general
mRNA export and provides a new mechanism by which
RBM15 facilitates the access of RNP remodeling factor
DBP5 to its substrate, general mRNA.
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